| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |